Puma Biotechnology Lands $55,000,000 New Financing Round

  • Feed Type
  • Date
    10/5/2011
  • Company Name
    Puma Biotechnology
  • Mailing Address
    10940 Wilshire Blvd Los Angeles, CA 90024
  • Company Description
    Puma Biotechnology, Inc. is a development-stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer.
  • Website
    http://www.pumabiotechnology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the private placement will be used primarily to fund the continued clinical development of neratinib.
  • M&A Terms
  • Venture Investor
    Adage Capital Management
  • Venture Investor
    Hambrecht & Quist Capital Management
  • Venture Investor
    OrbiMed